BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Soubise B, Jiang Y, Douet-Guilbert N, Troadec MB. RBM22, a Key Player of Pre-mRNA Splicing and Gene Expression Regulation, Is Altered in Cancer. Cancers (Basel) 2022;14:643. [PMID: 35158909 DOI: 10.3390/cancers14030643] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiménez-Vacas JM, Montero-Hidalgo AJ, Gómez-Gómez E, Sáez-Martínez P, Fuentes-Fayos AC, Closa A, González-Serrano T, Martínez-López A, Sánchez-Sánchez R, López-Casas PP, Sarmento-Cabral A, Olmos D, Eyras E, Castaño JP, Gahete MD, Luque RM. Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes. Transl Res 2023;253:68-79. [PMID: 36089245 DOI: 10.1016/j.trsl.2022.08.016] [Reference Citation Analysis]
2 Roca-Martínez J, Dhondge H, Sattler M, Vranken WF. Deciphering the RRM-RNA recognition code: A computational analysis. PLoS Comput Biol 2023;19:e1010859. [PMID: 36689472 DOI: 10.1371/journal.pcbi.1010859] [Reference Citation Analysis]
3 Jian W, Xue W, Wang T, Yu Y, Cai L, Meng Y, Xia Z, Zhang C. RBM4 inhibits the growth of clear cell renal cell carcinoma by enhancing the stability of p53 mRNA. Mol Carcinog 2022. [PMID: 36585906 DOI: 10.1002/mc.23499] [Reference Citation Analysis]
4 Douet-guilbert N, Soubise B, Bernard DG, Troadec M. Cytogenetic and Genetic Abnormalities with Diagnostic Value in Myelodysplastic Syndromes (MDS): Focus on the Pre-Messenger RNA Splicing Process. Diagnostics 2022;12:1658. [DOI: 10.3390/diagnostics12071658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]